Provided by Tiger Fintech (Singapore) Pte. Ltd.

LAVA Therapeutics N.V.

1.31
0.0000
Post-market: 1.30-0.0100-0.76%16:38 EDT
Volume:6.99K
Turnover:9.20K
Market Cap:34.46M
PE:-1.26
High:1.32
Open:1.31
Low:1.31
Close:1.31
Loading ...
Apr 20, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 24, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 28, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 08, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 31, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Mar 31, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 31, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Mar 24, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Mar 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 18, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 18, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Mar 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 02, 2021

Public Prospectus

F-1 - Registration statement for certain foreign private issuers